BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kuorda H, Abe T, Fujiwara Y, Okamoto T, Yonezawa M, Sato H, Endo K, Oikawa T, Sawara K, Takikawa Y. Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma. World J Gastroenterol 2019; 25(19): 2365-2372 [PMID: 31148907 DOI: 10.3748/wjg.v25.i19.2365]
URL: https://www.wjgnet.com/1007-9327/full/v25/i19/2365.htm
Number Citing Articles
1
Teiji Kuzuya, Masatoshi Ishigami, Takanori Ito, Yoji Ishizu, Takashi Honda, Tetsuya Ishikawa, Mitsuhiro Fujishiro. Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinomaHepatology Research 2020; 50(3): 374 doi: 10.1111/hepr.13452
2
Hiroyuki Suzuki, Hideki Iwamoto, Takashi Niizeki, Shigeo Shimose, Tomotake Shirono, Taizo Yamaguchi, Hirohisa Yano, Yasuji Okuda, Hironori Koga, Takuji Torimura. A long-term survival case of advanced hepatocellular carcinoma treated with multidisciplinary therapies with progression to hepatic arterial infusion chemotherapy and hepatectomyKanzo 2020; 61(8): 418 doi: 10.2957/kanzo.61.418
3
Yan Zhao, Ya-Ni Zhang, Kai-Ting Wang, Lei Chen. Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(1): 188391 doi: 10.1016/j.bbcan.2020.188391
4
Martina Catalano, Andrea Casadei-Gardini, Gianmarco Vannini, Claudia Campani, Fabio Marra, Enrico Mini, Giandomenico Roviello. Lenvatinib: Established and Promising Drug for the Treatment of Advanced Hepatocellular CarcinomaExpert Review of Clinical Pharmacology 2021;  doi: 10.1080/17512433.2021.1958674
5
Tantawi, MD Mohamed, Liu, MD Ji-Bin, R Eisenbrey, PhD John. Recent Advances in Microbubble-Augmented Cancer TherapyADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY 2020; 4(3): 155 doi: 10.37015/AUDT.2020.200055
6
Zhi-ting Xu, Hong Ding, Ben-gang Wang, Tian-tian Fu, Yu-li Zhu, Wen-ping Wang, Feng Lin. Savitzky-Golay Filter Based Quantitative Dynamic Contrast-Enhanced Ultrasound on Assessing Therapeutic Response in Mice with Hepatocellular CarcinomaJournal of Signal Processing Systems 2020; 92(3): 315 doi: 10.1007/s11265-019-01500-6
7
Hugh McGregor, Christopher Brunson, Gregory Woodhead, Abdul Khan, Charles Hennemeyer, Mikin Patel. Quantitative Assessment of the Hemodynamic Effects of Intra-Arterial Nitroglycerin on Hepatocellular Carcinoma using Two-Dimensional Perfusion AngiographyJournal of Vascular and Interventional Radiology 2021; 32(2): 198 doi: 10.1016/j.jvir.2020.10.023
8
Takeshi Hatanaka, Atsushi Naganuma, Satoru Kakizaki. Lenvatinib for Hepatocellular Carcinoma: A Literature ReviewPharmaceuticals 2021; 14(1): 36 doi: 10.3390/ph14010036
9
Ernst Michael Jung, Yi Dong. Contrast-Enhanced Ultrasound Imaging of Hepatic Neoplasms2021; : 251 doi: 10.1007/978-981-16-1761-4_13
10
Ernst Michael Jung, Yi Dong. Contrast-Enhanced Ultrasound Imaging of Hepatic Neoplasms2021; : 241 doi: 10.1007/978-981-16-1761-4_12
11
Kazuhiro Takahashi, Jaejeong Kim, Amane Takahashi, Shinji Hashimoto, Manami Doi, Kinji Furuya, Ryosuke Hashimoto, Yohei Owada, Koichi Ogawa, Yusuke Ohara, Yoshimasa Akashi, Katsuji Hisakura, Tsuyoshi Enomoto, Osamu Shimomura, Masayuki Noguchi, Tatsuya Oda. Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case reportWorld Journal of Hepatology 2021; 13(3): 384-392 doi: 10.4254/wjh.v13.i3.384
12
Shohei Komatsu, Yoshihiko Yano, Keitaro Sofue, Masahiro Kido, Motofumi Tanaka, Kaori Kuramitsu, Masahide Awazu, Hidetoshi Gon, Atsushi Yamamoto, Hiroaki Yanagimoto, Hirochika Toyama, Yuzo Kodama, Takamichi Murakami, Takumi Fukumoto. Assessment of lenvatinib treatment for unresectable hepatocellular carcinoma with liver cirrhosisHPB 2020; 22(10): 1450 doi: 10.1016/j.hpb.2020.03.002